Cleveland BioLabs Moving Key Operations To Russia For Faster Approvals
This article was originally published in PharmAsia News
Executive Summary
Cleveland BioLabs, a U.S. biotechnology company that developed cancer and radiation-treatments, plans to move much of its operations from the U.S. to Russia.